Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
1.500
-0.090 (-5.66%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Precigen Market Cap
Precigen has a market cap or net worth of $441.06 million as of April 25, 2025. Its market cap has increased by 25.66% in one year.
Market Cap
441.06M
Enterprise Value
348.66M
1-Year Change
25.66%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since August 8, 2013, Precigen's market cap has decreased from $2.32B to $441.06M, a decrease of -80.99%. That is a compound annual growth rate of -13.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 441.10M | 34.48% |
| Dec 31, 2024 | 328.00M | -1.68% |
| Dec 29, 2023 | 333.60M | 5.44% |
| Dec 30, 2022 | 316.40M | -58.75% |
| Dec 31, 2021 | 767.00M | -59.45% |
| Dec 31, 2020 | 1.89B | 112.19% |
| Dec 31, 2019 | 891.50M | -0.66% |
| Dec 31, 2018 | 897.40M | -35.47% |
| Dec 29, 2017 | 1.39B | -51.74% |
| Dec 30, 2016 | 2.88B | -17.89% |
| Dec 31, 2015 | 3.51B | 26.82% |
| Dec 31, 2014 | 2.77B | 19.88% |
| Dec 31, 2013 | 2.31B | -0.51% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |